Literature DB >> 22421533

Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.

Lucas Silvestroff1, Sandra Bartucci, Juana Pasquini, Paula Franco.   

Abstract

Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the Central Nervous System which is characterized by multifocal demyelinated lesions dispersed throughout the brain. Although white matter lesions have been the most extensively studied, cortical demyelinaton lesions are also detected in MS brains. Cuprizone (CPZ)-induced demyelination in rodents has been widely used as a model for MS. Most of these studies focus on oligodendrocyte-rich structures, such as the corpus callosum (CC) and the cerebellar peduncles. However, it has been recently described that CPZ administration in mice also produces cortical demyelination, resembling some of the lesions found in MS patients. In this work we used CPZ-demyelinating model in Wistar rats to study demyelination in cortical forebrain areas. At the ultrastructural level, demyelination in the cortex was observed before detectable myelin loss in the subcortical white matter. During the course of CPZ intoxication Myelin Basic Protein immunodetection was decreased in cortical layers I-III due to a reduction in the number of cortical oligodendrocytes (OL). Oligodendroglial loss in CPZ-intoxicated rats correlated with an increase in the number of Glial Fibrillary Acidic Protein positive astrocytes and a shift in the location of Carbonic Anhydrase II from OL to astrocytes. After removal of CPZ from the diet, we evaluate intranasal Thyroid hormone (TH) effects on the progression of cortical lesions. As previously reported in the CC, TH treatment also accelerates remyelination rate in the cortex compared to rats undergoing spontaneous remyelination. Our results suggest that manipulation of TH levels could be considered as a strategy to promote remyelination process in the cortex and to prevent neuronal irreversible damage in patients suffering from MS.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22421533     DOI: 10.1016/j.expneurol.2012.02.018

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  22 in total

Review 1.  Thyroid Hormone Signaling in Oligodendrocytes: from Extracellular Transport to Intracellular Signal.

Authors:  Jae Young Lee; Steven Petratos
Journal:  Mol Neurobiol       Date:  2016-07-18       Impact factor: 5.590

Review 2.  The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.

Authors:  Robert P Murphy; Keith J Murphy; Mark Pickering
Journal:  Bioengineered       Date:  2012-11-12       Impact factor: 3.269

3.  Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.

Authors:  Adib Zendedel; Iraj Ragerdi Kashani; Maryam Azimzadeh; Parichehr Pasbakhsh; Negar Omidi; Abolfazl Golestani; Cordian Beyer; Tim Clarner
Journal:  Metab Brain Dis       Date:  2016-01-04       Impact factor: 3.584

Review 4.  Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.

Authors:  Li-Jin Chew; Cynthia A DeBoy
Journal:  Neuropharmacology       Date:  2015-06-24       Impact factor: 5.250

5.  Myelin repair stimulated by CNS-selective thyroid hormone action.

Authors:  Meredith D Hartley; Tania Banerji; Ian J Tagge; Lisa L Kirkemo; Priya Chaudhary; Evan Calkins; Danielle Galipeau; Mitra D Shokat; Margaret J DeBell; Shelby Van Leuven; Hannah Miller; Gail Marracci; Edvinas Pocius; Tapasree Banerji; Skylar J Ferrara; J Matthew Meinig; Ben Emery; Dennis Bourdette; Thomas S Scanlan
Journal:  JCI Insight       Date:  2019-04-18

6.  Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.

Authors:  Mao Zhang; Xiao L Zhan; Zi Y Ma; Xing S Chen; Qi Y Cai; Zhong X Yao
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-10

Review 7.  Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.

Authors:  Yueting Zhang; Taylor B Guo; Hongtao Lu
Journal:  Neurosci Bull       Date:  2013-04-05       Impact factor: 5.203

Review 8.  Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.

Authors:  Mao Zhang; Ziyi Ma; Haochen Qin; Zhongxiang Yao
Journal:  Mol Neurobiol       Date:  2015-08-05       Impact factor: 5.590

9.  Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone.

Authors:  Haiyun Xu; Hong-Ju Yang; Xin-Min Li
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-06-01       Impact factor: 5.270

Review 10.  Regenerating CNS myelin - from mechanisms to experimental medicines.

Authors:  Robin J M Franklin; Charles Ffrench-Constant
Journal:  Nat Rev Neurosci       Date:  2017-11-16       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.